Li Y, XinBlau D, MCaballero M, TFeikin D, RGill C, JMadhi S, AOmer S, BSimões E, AFCampbell. Harry. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047–64.
Google Scholar
Ratti C, Greca AD, Bertoncelli D, Rubini M, Tchana B. Prophylaxis protects infants with congenital heart disease from severe forms of RSV infection: an Italian observational retrospective study: Palivizumab prophylaxis in children with congenital heart disease. Ital J Pediatr. 2023;49(1):4.
Google Scholar
Mavunda K, Jiang X, Ambrose CS. Prevalence and clinical characteristics of perinatal chronic lung disease by infant gestational age. J Neonatal Perinat Med. 2021;14(1):43–51.
Google Scholar
Kenmoe S, Kengne-Nde C, Modiyinji AF, La Rosa G, Njouom R. Comparison of health care resource utilization among preterm and term infants hospitalized with human respiratory Syncytial Virus infections: a systematic review and meta-analysis of retrospective cohort studies. PLoS ONE. 2020;15(2):e0229357.
Google Scholar
Scheltema NM, Elisabeth EPouw, JuliëtteBlanken M, ORovers M, MNaaktgeboren C, AMazur N, IWildenbeest. Joanne Gvan Der Ent, Cornelis KBont, Louis J. Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial. Lancet Respiratory Med. 2018;6(4):257–64.
Google Scholar
Smithgall M, Maykowski P, Zachariah P, Oberhardt M, Vargas CY, Reed C, et al. Epidemiology, clinical features, and resource utilization associated with respiratory syncytial virus in the community and hospital. Influenza Other Respir Viruses. 2020;14(3):247–56.
Google Scholar
Bont L, Checchia PA, Fauroux B, Figueras-Aloy J, Manzoni P, Paes B, et al. Defining the epidemiology and burden of severe respiratory syncytial virus infection among infants and children in western countries. Infect Dis Therapy. 2016;5:271–98.
Google Scholar
Jung JW. Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey. Korean J Pediatr. 2011;54(5):192.
Google Scholar
Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588–98.
Google Scholar
Wang X, Li Y, Nair H, Campbell H. Time-varying Association between severe respiratory Syncytial Virus infections and subsequent severe asthma and wheeze and influences of age at the infection. J Infect Dis. 2022;226(Suppl 1):S38–44.
Google Scholar
Ledbetter J, Brannman L, Wade SW, Gonzales T, Kong AM. Healthcare resource utilization and costs in the 12 months following hospitalization for respiratory syncytial virus or unspecified bronchiolitis among infants. J Med Econ. 2020;23(2):139–47.
Google Scholar
Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr. 2003;143(5 Suppl):S112–7.
Google Scholar
Greenough A, Cox S, Alexander J, Lenney W, Turnbull F, Burgess S, et al. Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child. 2001;85(6):463–8.
Google Scholar
Broughton S, Bhat R, Roberts A, Zuckerman M, Rafferty G, Greenough A. Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants. Arch Dis Child. 2006;91(1):26–30.
Google Scholar
Cilla G, Oñate E, Perez-Yarza EG, Montes M, Vicente D, Perez‐Trallero E. Viruses in community‐acquired pneumonia in children aged less than 3 years old: high rate of viral coinfection. J Med Virol. 2008;80(10):1843–9.
Google Scholar
Ambrose CS, Anderson EJ, Simões EA, Wu X, Elhefni H, Park CL, et al. Respiratory syncytial virus disease in preterm infants in the US born at 32–35 weeks gestation not receiving immunoprophylaxis. Pediatr Infect Dis J. 2014;33(6):576–82.
Google Scholar
Cai W, Tolksdorf K, Hirve S, Schuler E, Zhang W, Haas W, et al. Evaluation of using ICD-10 code data for respiratory syncytial virus surveillance. Influenza Other Respir Viruses. 2020;14(6):630–7.
Google Scholar
Bourdeau M, Vadlamudi NK, Bastien N, Embree J, Halperin SA, Jadavji T, et al. Pediatric RSV-Associated hospitalizations before and during the COVID-19 pandemic. JAMA Netw Open. 2023;6(10):e2336863.
Google Scholar
Kim JH, Kim HY, Lee M, Ahn JG, Baek JY, Kim MY, et al. Respiratory Syncytial Virus Outbreak without Influenza in the Second Year of the Coronavirus Disease 2019 pandemic: a National Sentinel Surveillance in Korea, 2021–2022 season. J Korean Med Sci. 2022;37(34):e258.
Google Scholar
Li Y, Wang X, Cong B, Deng S, Feikin DR, Nair H. Understanding the potential drivers for respiratory Syncytial Virus Rebound during the Coronavirus Disease 2019 Pandemic. J Infect Dis. 2022;225(6):957–64.
Google Scholar
Maltezou HC, Papanikolopoulou A, Vassiliu S, Theodoridou K, Nikolopoulou G, Sipsas NV. COVID-19 and respiratory virus co-infections: a systematic review of the literature. Viruses. 2023;15(4):865.
Google Scholar
Kim L, Kim J-A, Kim S. A guide for the utilization of health insurance review and assessment service national patient samples. Epidemiol Health. 2014;36.
Kyoung DS, Kim HS. Understanding and utilizing claim data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) database for research. J Lipid Atheroscler. 2022;11(2):103–10.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of Observational studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–9.
Google Scholar
Cha JSYKSKIGJ. Sentinel Surveillance results for Influenza and Acute Respiratory infections during the Coronavirus Disease 2019 Pandemic. Public Health Wkly Rep. 2023;16(20):597–612.
Group I-RS. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102(3):531–7.
Google Scholar
Hedberg P, Abdel-Halim L, Valik JK, Alfvén T, Nauclér P. Outcomes of Pediatric SARS-CoV-2 Omicron infection vs influenza and respiratory Syncytial Virus infections. JAMA Pediatr. 2024;178(2):197–9.
Google Scholar
Kobayashi Y, Togo K, Agosti Y, McLaughlin JM. Epidemiology of respiratory syncytial virus in Japan: a nationwide claims database analysis. Pediatr Int. 2022;64(1):e14957.
Google Scholar
Gantenberg JR, van Aalst R, Zimmerman N, Limone B, Chaves SS, La Via WV, et al. Medically attended illness due to respiratory syncytial virus infection among infants born in the United States between 2016 and 2020. J Infect Dis. 2022;226(Supplement2):S164–74.
Google Scholar
Hamilton MA, Calzavara A, Emerson SD, Djebli M, Sundaram ME, Chan AK, et al. Validating International classification of Disease 10th revision algorithms for identifying influenza and respiratory syncytial virus hospitalizations. PLoS ONE. 2021;16(1):e0244746.
Google Scholar
Johannesen CK, van Wijhe M, Tong S, Fernández LV, Heikkinen T, van Boven M, et al. Age-specific estimates of respiratory syncytial virus-associated hospitalizations in 6 European countries: a time series analysis. J Infect Dis. 2022;226(Supplement1):S29–37.
Google Scholar
OECD, OECD Health Statistics 2023; 2023. https://www.oecd.org/health/health-data.htm
Lee JY, Park J, Lee M, Han M, Lim SM, Baek JY et al. Rising Public Cost of Preterm Infant Hospitalization: A nationwide observational study in South Korea. 2023.
Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143(5):127–32.
Google Scholar
Doucette A, Jiang X, Fryzek J, Coalson J, McLaurin K, Ambrose CS. Trends in respiratory syncytial virus and bronchiolitis hospitalization rates in high-risk infants in a United States nationally representative database, 1997–2012. PLoS ONE. 2016;11(4):e0152208.
Google Scholar
Gouyon J-B, Roze J-C, Guillermet-Fromentin C, Glorieux I, Adamon L, Di Maio M, et al. Hospitalizations for respiratory syncytial virus bronchiolitis in preterm infants at < 33 weeks gestation without bronchopulmonary dysplasia: the CASTOR study. Epidemiol Infect. 2013;141(4):816–26.
Google Scholar
Suh M, Movva N, Jiang X, Bylsma LC, Reichert H, Fryzek JP, et al. Respiratory syncytial virus is the leading cause of United States infant hospitalizations, 2009–2019: a study of the national (nationwide) inpatient sample. J Infect Dis. 2022;226(Supplement2):S154–63.
Google Scholar
Suh M, Movva N, Jiang X, Reichert H, Bylsma LC, Fryzek JP, et al. Respiratory syncytial virus burden and healthcare utilization in United States infants < 1 year of age: study of nationally representative databases, 2011–2019. J Infect Dis. 2022;226(Supplement2):S184–94.
Google Scholar
Packnett ER, Winer IH, Oladapo A, Wojdyla M. Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29–34 wGA) infants without outpatient palivizumab administration. Hum Vaccin Immunother. 2023;19(2):2252289.
Google Scholar
McLaurin KK, Farr AM, Wade SW, Diakun DR, Stewart DL. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants. J Perinatol. 2016;36(11):990–6.
Google Scholar
Shi N, Palmer L, Chu B-C, Katkin JP, Hall CB, Masaquel AS, et al. Association of RSV lower respiratory tract infection and subsequent healthcare use and costs: a Medicaid claims analysis in early-preterm, late-preterm, and full-term infants. J Med Econ. 2011;14(3):335–40.
Google Scholar
Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545–55.
Google Scholar
Choi EJ. Policy measures for the management of Health statistics on premature live births. Health Welf Forum. 2023;2023(3):81–95.
Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 2023;21(3):195–210.
Google Scholar
Kim YK, Song SH, Ahn B, Lee JK, Choi JH, Choi S-H et al. Shift in clinical epidemiology of human parainfluenza virus type 3 and respiratory syncytial virus B infections in Korean children before and during the COVID-19 pandemic: a multicenter retrospective study. J Korean Med Sci. 2022;37(28).
Kim HM, Lee EJ, Lee NJ, Woo SH, Kim JM, Rhee JE, et al. Impact of coronavirus disease 2019 on respiratory surveillance and explanation of high detection rate of human rhinovirus during the pandemic in the Republic of Korea. Influenza Other Respir Viruses. 2021;15(6):721–31.
Google Scholar
Chuang Y-C, Lin K-P, Wang L-A, Yeh T-K, Liu P-Y. The impact of the COVID-19 pandemic on respiratory syncytial virus infection: a narrative review. Infect Drug Resist. 2023;16:661–675.
American Academy of Pediatrics. Updated AAP guidance recommends longer breastfeeding due to benefits 2022. https://publications.aap.org/aapnews/news/20528/Updated-AAP-guidance-recommends-longer
Jang MJ, Kim YJ, Hong S, Na J, Hwang JH, Shin SM, et al. Positive association of breastfeeding on respiratory syncytial virus infection in hospitalized infants: a multicenter retrospective study. Clin Exp Pediatr. 2020;63(4):135–40.
Google Scholar
Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva M, Madhi SA, et al. Nirsevimab for Prevention of RSV in healthy late-preterm and term infants. N Engl J Med. 2022;386(9):837–46.
Google Scholar
link